However, the changes in the dynamic of the circulating levels of chitotriosidase and neopterin (pre- and post-surgery) support the possible use of these serum markers in the postoperative follow-up of patients with colorectal cancer. The gene discussed is CHIT1; the disease is colorectal cancer.